Skip to main content
Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · Real-Time Price · USD
0.120
0.00 (-0.17%)
At close: Dec 20, 2024, 3:52 PM
0.122
+0.003 (2.17%)
After-hours: Dec 20, 2024, 7:58 PM EST

Zomedica Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Zomedica.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for Zomedica.

Recommendation Trends

Rating Jan '23
Strong Buy 0
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 0

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jason Kolbert
Dawson James
 Dawson James
Strong Buy
Initiates
$6
 Strong Buy Initiates $6 +4,908.35% Jan 6, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
34.44M
from 25.19M
Increased by 36.75%
Revenue Next Year
39.58M
from 34.44M
Increased by 14.92%
EPS This Year
-0.01
from -0.04
EPS Next Year
n/a
from -0.01
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
--4.13M18.93M25.19M34.44M39.58M50.07M
Revenue Growth
---358.02%33.05%36.75%14.92%26.51%
EPS
-0.19-0.05-0.05-0.02-0.04-0.01--
EPS Growth
--------
Forward PE
--------
No. Analysts -----222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2024202520262027
High 35.8M 41.1M 52.1M
Avg 34.4M 39.6M 50.1M
Low 33.4M 38.4M 48.6M

Revenue Growth

Revenue Growth 2024202520262027
High
42.2%
19.5%
31.5%
Avg
36.7%
14.9%
26.5%
Low
32.7%
11.5%
22.8%

EPS Forecast

EPS 2024202520262027
High -0.01 - -
Avg -0.01 - -
Low -0.01 - -

EPS Growth

EPS Growth 2024202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.